4//SEC Filing
Quimi Daphne 4
Accession 0001209191-23-001394
CIK 0001178879other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 7:13 PM ET
Size
10.5 KB
Accession
0001209191-23-001394
Insider Transaction Report
Form 4
Quimi Daphne
Corporate Controller
Transactions
- Tax Payment
Common Stock
2023-01-02$12.21/sh−15,165$185,165→ 320,147 total - Award
Stock Options (right to buy)
2023-01-03+130,480→ 130,480 totalExercise: $11.93Exp: 2033-01-03→ Common Stock (130,480 underlying) - Tax Payment
Common Stock
2023-01-03$11.93/sh−8,575$102,300→ 385,080 total - Award
Common Stock
2023-01-03+73,508→ 393,655 total
Footnotes (2)
- [F1]Granted in the form of Restricted Stock Units ("RSUs"), these RSUs will vest in four equal annual installments beginning on January 3, 2024 and shall be payable in common stock. One (1) RSU is the equivalent of one (1) share of Amicus common stock.
- [F2]These options vest and become exercisable in a series of installments over a four year period with 25% vesting one year after the date of grant and the remaining 75% vesting ratably each month thereafter.
Documents
Issuer
AMICUS THERAPEUTICS, INC.
CIK 0001178879
Entity typeother
Related Parties
1- filerCIK 0001543031
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 7:13 PM ET
- Size
- 10.5 KB